课题基金 / 基金详情

HORMONAL CONTROL OF GLUCONEOGENESIS IN DIABETES MELLITUS

HORMONAL CONTROL OF GLUCONEOGENESIS IN DIABETES MELLITUS
糖尿病中糖异生的激素控制
批准号:
3081014
负责人:
JOHN A TAYEK
金额:
$9.29万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-01-01 至 1996-12-31

项目摘要

项目成果

JOHN A TAYEK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The focus of this research is to use a new and exciting methodology of stable isotopomer analysis to determine the hormonal mechanisms controlling gluconeogenesis. In order to understand the regulation of gluconeogenesis, it will be necessary to quantitate and verify the movement of gluconeogenic precursors through the tricarboxylic (TCA) cycle. Research in the quantification of gluconeogenesis has been hampered by the inability to determine 1) the rate of TCA cycle flux (citrate synthase) and 2) the dilution of tracer that occurs at the pyruvate carboxylase, dehydrogenase and kinase steps. Since lactate is believed to be the major contributor to overall gluconeogenesis, this research proposal will administer U-13C lactate and other related isotopes and perform stable isotopomer analysis to quantitate gluconeogenesis by determining the dilutional parameters of the TCA cycle. It is our hypothesis that diabetic patients have a defect in pyruvate dehydrogenase and a secondary increase in pyruvate carboxylase and fasting gluconeogenesis. This may be a primary defect or a secondary effect due to altered hormonal regulation. In order to evaluate the hormonal regulation of hepatic pyruvate dehydrogenase and carboxylase, we will perform pituitary pancreatic euglycemic clamp studies in normal volunteers to evaluate hormonal effects on TCA cycle metabolism. Similar studies will be performed in diabetic patients to test our overall hypothesis and determine if a defect in pyruvate dehydrogenase activity is responsible for the abnormal glucose metabolism known to occur in diabetic patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Arginine Treatment for Alcoholic Hepatitis
Arginine Treatment for Alcoholic Hepatitis
Arginine Treatment for Alcoholic Hepatitis
ABNORMAL GLUCONEOGENESIS IN TYPE II DIABETES
海外基金